NCT06193889 · Interventional trial
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Overall registry status Recruiting
Phase 2 · Phase 3
Conditions Generalized Myasthenia Gravis, Myasthenia Gravis
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory